Cargando…

Current Advances in Humanized Mouse Models for Studying NK Cells and HIV Infection

Human immunodeficiency virus (HIV) has infected millions of people worldwide and continues to be a major global health problem. Scientists required a small animal model to study HIV pathogenesis and immune responses. To this end, humanized mice were created by transplanting human cells and/or tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jocelyn T., Bresson-Tan, Gabrielle, Zack, Jerome A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458594/ https://www.ncbi.nlm.nih.gov/pubmed/37630544 http://dx.doi.org/10.3390/microorganisms11081984

Ejemplares similares

A humanized mouse model to study NK cell biology during HIV infection
por: Kim, Jocelyn T., et al.
Publicado: (2022)

Comparing Current and Next-Generation Humanized Mouse Models for Advancing HIV and HIV/Mtb Co-Infection Studies
por: Lepard, Madeleine, et al.
Publicado: (2022)

Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses
por: Gillgrass, Amy, et al.
Publicado: (2021)

NK Cells in Protection from HIV Infection
por: Bernard, Nicole F., et al.
Publicado: (2022)

Human NK cells confer protection against HIV-1 infection in humanized mice
por: Sungur, Can M., et al.
Publicado: (2022)

Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections
por: Manickam, Cordelia, et al.
Publicado: (2019)

NK Cells and immune activation in HIV-1 infection
por: Goodier, Martin R
Publicado: (2010)

NK Cells in HIV Disease
por: Scully, Eileen, et al.
Publicado: (2016)

IL-10(+) NK and TGF-β(+) NK cells play negative regulatory roles in HIV infection
por: Jiang, Yongjun, et al.
Publicado: (2018)

Altered distribution of mucosal NK cells during HIV infection
por: Sips, Magdalena, et al.
Publicado: (2011)

Alterations of the NK cell pool in HIV/HCV co-infection
por: Kaczmarek, Dominik J., et al.
Publicado: (2017)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Heipertz, Erica L., et al.
Publicado: (2021)

Cocaine-mediated impact on HIV infection in humanized BLT mice
por: Kim, Sohn G., et al.
Publicado: (2015)

HIV restriction in quiescent CD4(+) T cells
por: Zack, Jerome A, et al.
Publicado: (2013)

Novel Mouse Model of Murine Cytomegalovirus–Induced Adaptive NK Cells
por: Jensen, Isaac J., et al.
Publicado: (2022)

Identification of Human NK17/NK1 Cells
por: Pandya, Abhilash D., et al.
Publicado: (2011)

PD-1 expression on mouse intratumoral NK cells and its effects on NK cell phenotype
por: Wagner, Arnika K., et al.
Publicado: (2022)

Intrinsic Contribution of Perforin to NK-Cell Homeostasis during Mouse Cytomegalovirus Infection
por: Arapović, Maja, et al.
Publicado: (2016)

Peptide Adjuvant to Invigorate Cytolytic Activity of NK Cells in an Obese Mouse Cancer Model
por: Han, Seungmin, et al.
Publicado: (2021)

NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies
por: Flórez-Álvarez, Lizdany, et al.
Publicado: (2018)

Comparative Efficiency of HIV-1-Infected T Cell Killing by NK Cells, Monocytes and Neutrophils
por: Smalls-Mantey, Adjoa, et al.
Publicado: (2013)

Effects of obesity on NK cells in a mouse model of postmenopausal breast cancer
por: Spielmann, Julia, et al.
Publicado: (2020)

NK cells and poxvirus infection
por: Burshtyn, Deborah N.
Publicado: (2013)

NK cells control HIV‐1 infection of macrophages through soluble factors and cellular contacts in the human decidua
por: Quillay, H., et al.
Publicado: (2016)

Advances in NK cell therapy for brain tumors
por: Fares, Jawad, et al.
Publicado: (2023)

Advances and challenges of immunotherapies in NK/T cell lymphomas
por: He, Ling, et al.
Publicado: (2023)

CD56(neg)CD16(+) NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
por: Milush, Jeffrey M, et al.
Publicado: (2013)

Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers
por: Zhang, Zhi, et al.
Publicado: (2021)

Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge
por: Kwant-Mitchell, Amanda, et al.
Publicado: (2009)

Aggressive NK Cell Leukemia: Current State of the Art
por: El Hussein, Siba, et al.
Publicado: (2020)

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
por: Brown, Bruce K., et al.
Publicado: (2012)

Regulation of Mouse NK Cell Development and Function by Cytokines
por: Marçais, Antoine, et al.
Publicado: (2013)

Human NK Cell Diversity in Viral Infection: Ramifications of Ramification
por: Strauss-Albee, Dara M., et al.
Publicado: (2016)

Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
por: Tschan-Plessl, Astrid, et al.
Publicado: (2016)

Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse
por: Endsley, Janice J., et al.
Publicado: (2021)

NK Cells in the Human Lungs
por: Hervier, Baptiste, et al.
Publicado: (2019)

Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal
por: Moran, Jose A., et al.
Publicado: (2023)

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets
por: Mace, Emily M., et al.
Publicado: (2016)

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality
por: Persyn, Eva, et al.
Publicado: (2022)

Novel Mouse Xenograft Models Reveal a Critical Role of CD4(+) T Cells in the Proliferation of EBV-Infected T and NK Cells
por: Imadome, Ken-Ichi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vtod9e9m4crhe5edpjna9643e2